Atlas Trials

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Clinical trial NCT02620865 · COMPLETED

Trial details

NCT number
NCT02620865
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage III Pancreatic CancerStage IV Pancreatic Cancer
Start date
2015-12-01
Primary completion
2021-06-21
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.